About the Authors

Helen J. Huang

Contributed equally to this work with: Helen J. Huang, Laura S. Angelo

Affiliation Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

Laura S. Angelo

Contributed equally to this work with: Helen J. Huang, Laura S. Angelo

Affiliation Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

Jordi Rodon

Affiliations Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America, Servei d'Oncologia Medica, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Michael Sun

Affiliation Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

Klaus-Peter Kuenkele

Affiliation Roche Diagnostics GmbH, Penzberg, Germany

Henrique A. Parsons

Affiliation Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

Jonathan C. Trent

Affiliation Division of Cancer Medicine, Department of Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

Razelle Kurzrock

rkurzroc@mdanderson.org

Affiliation Phase I Program, Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: RK HJH LSA MS JR. Performed the experiments: HJH LSA MS. Analyzed the data: RK LSA JR KPK HAP. Contributed reagents/materials/analysis tools: JCT KPK HAP. Wrote the paper: LSA RK.